|
2026 Journal Article Peri-coronary inflammation and coronary microcalcification activity in subjects with diabetes mellitus; a cross-sectional analysisSmith, Brodie, Bellinge, Brynn, Francis, Roslyn J., Parry, Reece, Lee, Sing Ching, Bellinge, Jamie W. and Schultz, Carl J. (2026). Peri-coronary inflammation and coronary microcalcification activity in subjects with diabetes mellitus; a cross-sectional analysis. Journal of Diabetes and its Complications, 40 (5) 109316, 109316. doi: 10.1016/j.jdiacomp.2026.109316 |
|
2026 Journal Article Predictive value of early PSMA upregulation for the response to enzalutamide ± <SUP>177</SUP>Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trialEmmett, Louise, Swiha, Mina, Papa, Nathan, Subramaniam, Shalini, Crumbaker, Megan, Joshua, Anthony, Nguyen, Andrew, Weickhardt, Andrew, Lee, Sze-Ting, Ng, Siobhan, Francis, Roslyn, Goh, Jeffrey, Pattison, David, Pathmanandavel, Sarennya, Hope, Thomas, Ayati, Narjess, Hofman, Michael, Sandhu, Shahneen, Niu, Claire, Martin, Andrew, Thomas, Hayley, Stockler, Martin and Davis, Ian (2026). Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial. Nature Cancer, 7 (4), 622-630. doi: 10.1038/s43018-026-01140-3 |
|
2026 Journal Article <sup>177</sup> Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate CancerAyati, Narjess, Papa, Nathan, Crumbaker, Megan, Subramaniam, Shalini, Joshua, Anthony M., Alipour, Ramin, Iravani, Amir, Askari, Emran, Khan, Sobia, Yadav, Surekha, Eiber, Matthias, Weickhardt, Andrew, Lee, Sze-Ting, Ng, Siobhan, Francis, Roslyn J., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Nguyen, Andrew, Hofman, Michael S., Sandhu, Shahneen, Hioki, Takanori, van Oorschodt, Julian C. J., Devitt, Katrina, Willowson, Kathy, Sharma, Shikha, Stancu, Alexandru, Chauvie, Stephane ... on behalf of the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group (2026). 177 Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer. Radiology, 319 (1) e252672. doi: 10.1148/radiol.252672 |
|
2026 Journal Article Clonal hematopoiesis after 177Lu-PSMA-617 radioligand therapy in prostate cancerMunzur, Aslı D., Herberts, Cameron, Kwan, Edmond M., Emmett, Louise, Sandhu, Shahneen, Buteau, James P., Iravani, Amir, Joshua, Anthony M., Francis, Roslyn J., Lee, Sze-Ting, Scott, Andrew M., Martin, Andrew J., Stockler, Martin R., Zhang, Alison Y., Williams, Scott G., Bernales, Cecily Q., Donnellan, Gráinne, Koudjanian, Melissa, Parekh, Karan, Bacon, Jack V. W., Karsan, Aly, Azad, Arun A., Davis, Ian D., Hofman, Michael S. and Wyatt, Alexander W. (2026). Clonal hematopoiesis after 177Lu-PSMA-617 radioligand therapy in prostate cancer. Clinical Cancer Research, OF1-OF9. doi: 10.1158/1078-0432.ccr-25-4001 |
|
2026 Journal Article RECIP 1.0 more predictive of overall survival than PSMA PET progression criteria in biochemically recurrent prostate cancerMolin, Kaylee, Ong, Jeremy S. L., Werf, Steven Van Der, Francis, Roslyn J., Hassan, Ghulam Mubashar, Ebert, Martin A. and Kendrick, Jake (2026). RECIP 1.0 more predictive of overall survival than PSMA PET progression criteria in biochemically recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 53 (4), 2234-2244. doi: 10.1007/s00259-025-07592-6 |
|
2026 Journal Article Persistent lung and vascular inflammation in mild to moderate COVID-19 survivors detected by ¹⁸F-FDG PET/CT: A quantitative imaging study with implications for cardiovascular riskVerma, Shipra, Lan, Nick S. R., Espedal, Heidi, Ong, Jeremy, Roy, Ambuj, Ahmad, Adilah, Ali, Kamar, Ward, Natalie C., Patel, Sanjay, Parizel, Paul M., Francis, Roslyn J. and Dwivedi, Girish (2026). Persistent lung and vascular inflammation in mild to moderate COVID-19 survivors detected by ¹⁸F-FDG PET/CT: A quantitative imaging study with implications for cardiovascular risk. European Journal of Nuclear Medicine and Molecular Imaging, 53 (5), 3246-3257. doi: 10.1007/s00259-025-07656-7 |
|
2026 Journal Article Deep learning-based PSMA PET segmentation repeatability: A post-hoc analysis of a single-center, prospective, test–retest trialKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Ong, Jeremy S. L., Jeraj, Robert, Barry, Nathaniel and Ebert, Martin A. (2026). Deep learning-based PSMA PET segmentation repeatability: A post-hoc analysis of a single-center, prospective, test–retest trial. Radiologia Medica, 131 (2), 320-331. doi: 10.1007/s11547-025-02137-1 |
|
2026 Journal Article SUBDUE-3: SUB-urothelial DUrvalumab-89zirconium injEction; a phase 0 biodistribution study protocolKeane, Kevin G., Gauci, Richard, Francis, Roslyn J., Scott, Andrew M., Hawks, Cynthia, Inderjeeth, Andrisha-Jade, Davis, Ian D., Lim, Jayne, Redfern, Andrew and Hayne, Dickon (2026). SUBDUE-3: SUB-urothelial DUrvalumab-89zirconium injEction; a phase 0 biodistribution study protocol. BJU International bju.70153. doi: 10.1111/bju.70153 |
|
2025 Journal Article Analysis of the impact of female sex and muscle mass on serum creatinine and waitlist priority for liver transplantationGupta, Shivangi, Jeffrey, Angus W., Wang, Zhengyi, Adams, Leon A., Garas, George, Macquillan, Gerry, Wallace, Michael C., Smith, Briohny, Lim, Wai H., Francis, Ros, Welman, Christopher J. and Jeffrey, Gary P. (2025). Analysis of the impact of female sex and muscle mass on serum creatinine and waitlist priority for liver transplantation. Liver Transplantation, 32 (5), 717-725. doi: 10.1097/LVT.0000000000000747 |
|
2025 Journal Article ARTnet perspectives and contributions to theranosticsFrancis, Roslyn J., Bailey, Dale L., Willowson, Kathy, Latter, Melissa J., Chappell, Bridget, McGill, George, Hofman, Michael S., Emmett, Louise and Scott, Andrew M. (2025). ARTnet perspectives and contributions to theranostics. World Journal of Nuclear Medicine, 24 (3), 231-237. doi: 10.1055/s-0045-1812309 |
|
2025 Journal Article Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trialEmmett, Louise, Papa, Nathan, Subramaniam, Shalini, Crumbaker, Megan, Nguyen, Andrew, Joshua, Anthony M, Sandhu, Shahneen, Weickhardt, Andrew, Lee, Sze-Ting, Ng, Siobhan, Francis, Roslyn J, Goh, Jeffrey C, Pattison, David A, Tan, Thean Hsiang, Kirkwood, Ian D, Ayati, Narjess, Niu, Claire, Hofman, Michael S, Martin, Andrew James, Thomas, Hayley, Davis, Ian D, Stockler, Martin R and Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2025). Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology, 26 (9), 1168-1177. doi: 10.1016/S1470-2045(25)00339-0 |
|
2025 Journal Article Fluorodeoxyglucose positron emission tomography detects persistent arterial inflammation after symptomatic COVID-19Espedal, Heidi, Verma, Shipra, Roy, Ambuj, Lan, Nick S.R., Mohd, Sheeraz, Bartlett, Benjamin, Ali, Kamar, Ward, Natalie C., Ebert, Martin A., Chan, Dick C., Watts, Gerald F., Dwivedi, Girish and Francis, Roslyn J. (2025). Fluorodeoxyglucose positron emission tomography detects persistent arterial inflammation after symptomatic COVID-19. Heart Lung and Circulation, 34 (9), 969-976. doi: 10.1016/j.hlc.2025.03.005 |
|
2025 Journal Article The effect of oral colchicine and vitamin K1 on bone metabolism in patients with diabetes mellitus: A post-hoc analysis of a 2 × 2 factorial randomized controlled trial with 18F-sodium fluoride positron emission tomographyBellinge, Jamie W., Sim, Marc, Francis, Roslyn J., Lee, Sing Ching, Chan, Dick C., Girgis, Christian M., Watts, Gerald F., Lewis, Joshua R. and Schultz, Carl J. (2025). The effect of oral colchicine and vitamin K1 on bone metabolism in patients with diabetes mellitus: A post-hoc analysis of a 2 × 2 factorial randomized controlled trial with 18F-sodium fluoride positron emission tomography. Bone, 196 117492, 1-8. doi: 10.1016/j.bone.2025.117492 |
|
2025 Journal Article An external, independent validation of anO-(2-[18F]Fluoroethyl)-l-Tyrosine PET automatic segmentation network on a single-center, prospective dataset of patients with glioblastomaBarry, Nathaniel, Kendrick, Jake, Rowshanfarzad, Pejman, Hassan, Ghulam Mubashar, Francis, Roslyn J., Bucknell, Nicholas, Koh, Eng-Siew, Scott, Andrew M., Ebert, Martin A., Gutsche, Robin, Ciantar, Keith George, Galldiks, Norbert, Langen, Karl-Josef and Lohmann, Philipp (2025). An external, independent validation of anO-(2-[18F]Fluoroethyl)-l-Tyrosine PET automatic segmentation network on a single-center, prospective dataset of patients with glioblastoma. Journal of Nuclear Medicine, 66 (6), 948-953. doi: 10.2967/jnumed.124.268925 |
|
2025 Journal Article Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trialKwan, Edmond M., Ng, Sarah W. S., Tolmeijer, Sofie H., Emmett, Louise, Sandhu, Shahneen, Buteau, James P., Iravani, Amir, Joshua, Anthony M., Francis, Roslyn J., Subhash, Vinod, Lee, Sze-Ting, Scott, Andrew M., Martin, Andrew J., Stockler, Martin R., Donnellan, Grainne, Annala, Matti, Herberts, Cameron, Davis, Ian D., Hofman, Michael S., Azad, Arun A., Wyatt, Alexander W., Akhurst, Tim, Alipour, Ramin, Bailey, Dale L., Banks, Patricia, Beaulieu, Alexis, Campbell, Louise, Chua, Wei, Crumbaker, Megan ... on behalf of the TheraP Investigators and the ANZUP Cancer Trials Group (2025). Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial. Nature Medicine, 2025 (8), 1-15. doi: 10.1038/s41591-025-03704-9 |
|
2025 Journal Article Prevalence and medium-term outcomes of patients with biopsy-proven intermediate- to high-risk prostate adenocarcinoma with low intraprostatic uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA StudyChen, David C., Buteau, James P., Emmett, Louise, Alipour, Ramin, de Galiza Barbosa, Felipe, Roberts, Matthew J., McVey, Aoife, O’Brien, Jonathan, Levy, Sidney, Francis, Roslyn J., Lawrentschuk, Nathan, Murphy, Declan G. and Hofman, Michael S. (2025). Prevalence and medium-term outcomes of patients with biopsy-proven intermediate- to high-risk prostate adenocarcinoma with low intraprostatic uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study. Journal of Nuclear Medicine, 66 (5), 713-718. doi: 10.2967/jnumed.124.268901 |
|
2025 Journal Article Biopsy decision for intermediate–high-risk lung nodules is significantly changed when guided by prior positron emission tomography/CT (PET/CT) results: results of the prospective PET-FIRST studyFielding, David, Sidhu, Calvin, Alkhater, Mahmoud, Alawami, Moayed, Kops, Stephan E. P., van der Heijden, Erik H. F. M., Bashirzadeh, Farzad, Windsor, Morgan, Nixon, Elizabeth, Son, Jung Hwa, Ananda Setty, Niranjan, Pattison, David A., Fong, William, Bhatt, Manoj, Dhiantravan, Nattakorn, Ramsay, Stuart, Boots, Robert, Putt, Michael, Pratt, Gary, Bettington, Catherine, Francis, Roslyn, Thomas, Paul, Steinke, Karin and Thomas, Rajesh (2025). Biopsy decision for intermediate–high-risk lung nodules is significantly changed when guided by prior positron emission tomography/CT (PET/CT) results: results of the prospective PET-FIRST study. BMJ Open Respiratory Research, 12 (1) e002553, 1-10. doi: 10.1136/bmjresp-2024-002553 |
|
2025 Journal Article Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trialEmmett, Louise, Subramaniam, Shalini, Crumbaker, Megan, Joshua, Anthony M, Sandhu, Shahneen, Nguyen, Andrew, Weickhardt, Andrew, Lee, Sze-Ting, Ng, Siobhan, Francis, Roslyn J, Goh, Jeffrey C, Tan, Thean Hsiang, Kirkwood, Ian D, Gedye, Craig, Rutherford, Natalie K, Kumar, Aravind S Ravi, Pook, David, Ramdave, Shakher, Nadebaum, David P, Voskoboynik, Mark, Redfern, Andrew D, Macdonald, William, Krieger, Laurence, Schembri, Geoff, Chua, Wei, Lin, Peter, Horvath, Lisa, Bastick, Patricia, Butler, Patrick ... Bills, Madison (2025). Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology, 26 (3), 291-299. doi: 10.1016/s1470-2045(25)00009-9 |
|
2025 Journal Article Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [68Ga]Ga-PSMA-11 PET/CTMolin, Kaylee, Barry, Nathaniel, Gill, Suki, Hassan, Ghulam Mubashar, Francis, Roslyn J., Ong, Jeremy S. L., Ebert, Martin A. and Kendrick, Jake (2025). Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [68Ga]Ga-PSMA-11 PET/CT. Physical and Engineering Sciences in Medicine, 48 (1), 329-341. doi: 10.1007/s13246-024-01516-8 |
|
2025 Journal Article Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccineThunold, Solfrid, Hernes, Eivor, Farooqi, Saima, Öjlert, Åsa Kristina, Francis, Roslyn J., Nowak, Anna K., Szejniuk, Weronika Maria, Nielsen, Søren Steen, Cedres, Susana, Perdigo, Marc Simo, Sørensen, Jens Benn, Meltzer, Carin, Mikalsen, Lars Tore Gyland, Helland, Åslaug, Malinen, Eirik and Haakensen, Vilde Drageset (2025). Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine. European Journal of Nuclear Medicine and Molecular Imaging, 52 (2), 693-707. doi: 10.1007/s00259-024-06853-0 |
